Neutrophil to lymphocyte ratio is not related to carotid atherosclerosis progression and cardiovascular events in the primary prevention of cardiovascular disease: Results from the IMPROVE study

Inflammation is a component of the pathogenesis of atherosclerosis and is associated with an increased risk of atherosclerotic cardiovascular disease (ASCVD). The neutrophil to lymphocyte ratio (NLR) is a possible inflammation metric for the detection of ASCVD risk, although results of prospective studies are highly inconsistent on this topic. We investigated the cross‐sectional relationship between NLR and carotid intima‐media thickness (cIMT) in subjects at moderate‐to‐high ASCVD risk. The prospective association between NLR, cIMT progression, and incident vascular events (VEs) was also explored. In 3341 subjects from the IMT‐Progression as Predictors of VEs (IMPROVE) study, we analyzed the association between NLR, cIMT, and its 15‐month progression. The association between NLR and incident VEs was also investigated. NLR was positively associated with cross‐sectional measures of cIMT, but not with cIMT progression. The association between NLR and cross‐sectional cIMT measures was abolished when adjusted for confounders. No association was found between NRL and incident VEs. Similarly, there were no significant differences in the hazard ratios (HRs) of VEs across NLR quartiles. NLR was neither associated with the presence and progression of carotid atherosclerosis, nor with the risk of VEs. Our findings do not support the role of NLR as a predictor of the risk of atherosclerosis progression and ASCVD events in subjects at moderate‐to‐high ASCVD risk, in primary prevention. However, the usefulness of NLR for patients at a different level of ASCVD risk cannot be inferred from this study.

[1]  S. Benedetti,et al.  The association between neutrophil to lymphocyte ratio and endothelial dysfunction in people living with HIV on stable antiretroviral therapy , 2021, Expert review of anti-infective therapy.

[2]  P. Giral,et al.  The neutrophil-lymphocyte ratio and incident atherosclerotic events: the impact of racial differences? , 2021, European heart journal.

[3]  A. Yılmaz,et al.  Systemic immune-inflammation index is associated with increased carotid intima-media thickness in hypertensive patients , 2021, Clinical and experimental hypertension.

[4]  P. Libby,et al.  The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials. , 2021, European heart journal.

[5]  S. Bianchi,et al.  Association between neutrophil to lymphocyte ratio and carotid artery wall thickness in healthy pregnant women. , 2020, European journal of obstetrics, gynecology, and reproductive biology.

[6]  Baoli Li,et al.  The associations between neutrophil-to-lymphocyte ratio and the Chinese Visceral Adiposity Index, and carotid atherosclerosis and atherosclerotic cardiovascular disease risk , 2020, Experimental Gerontology.

[7]  S. Carranza-Lira,et al.  Relationship of the neutrophil/lymphocyte ratio with cardiovascular risk markers in premenopausal and postmenopausal women , 2020, Przeglad menopauzalny = Menopause review.

[8]  C. Rosales.  Neutrophils at the crossroads of innate and adaptive immunity , 2020, Journal of leukocyte biology.

[9]  O. Soehnlein,et al.  Neutrophils as regulators of cardiovascular inflammation , 2020, Nature Reviews Cardiology.

[10]  S. Bojesen,et al.  Incidental lymphopenia and mortality: a prospective cohort study , 2020, Canadian Medical Association Journal.

[11]  Gui-ling Liu,et al.  Neutrophil-to-lymphocyte ratio in relation to the risk of all-cause mortality and cardiovascular events in patients with chronic kidney disease: a systematic review and meta-analysis , 2020, Renal failure.

[12]  R. Diaz,et al.  Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. , 2019, The New England journal of medicine.

[13]  A. Khera,et al.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Journal of the American College of Cardiology.

[14]  P. Kubes,et al.  The Neutrophil's Role During Health and Disease. , 2019, Physiological reviews.

[15]  Deepak L. Bhatt,et al.  Arterial Inflammation: The Heat Before the Storm. , 2019, Journal of the American College of Cardiology.

[16]  A. Contreras-Ramos,et al.  Neutrophil‐to‐lymphocyte ratio and its relation with pro‐inflammatory mediators, visceral adiposity and carotid intima‐media thickness in population with obesity , 2019, European journal of clinical investigation.

[17]  J. Attia,et al.  Neutrophil Lymphocyte Ratio and Cardiovascular Disease Risk: A Systematic Review and Meta-Analysis , 2018, BioMed research international.

[18]  V. Fuster,et al.  Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week. , 2018, Journal of the American College of Cardiology.

[19]  M. Gianni,et al.  Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes: A systematic review and meta-analysis of the literature. , 2018, International journal of cardiology.

[20]  K. Kelsey,et al.  Association of Neutrophil-to-Lymphocyte Ratio With Mortality and Cardiovascular Disease in the Jackson Heart Study and Modification by the Duffy Antigen Variant , 2018, JAMA cardiology.

[21]  S. Johnston,et al.  Neutrophil counts, neutrophil ratio, and new stroke in minor ischemic stroke or TIA , 2018, Neurology.

[22]  G. Tarantino,et al.  Hematocrit Values Predict Carotid Intimal-Media Thickness in Obese Patients With Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study , 2018, Front. Endocrinol..

[23]  Si-Yu Chen,et al.  Neutrophil to lymphocyte ratio predict mortality and major adverse cardiac events in acute coronary syndrome: A systematic review and meta-analysis. , 2017, Clinical Biochemistry.

[24]  Bei Cheng,et al.  The clinical value of inflammatory biomarkers in coronary artery disease: PTX3 as a new inflammatory marker , 2017, Experimental Gerontology.

[25]  P. Libby,et al.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.

[26]  Shixiang Wang,et al.  High Neutrophil-to-Lymphocyte Ratio Predicts Cardiovascular Mortality in Chronic Hemodialysis Patients , 2017, Mediators of inflammation.

[27]  Binita Shah,et al.  Relationship between neutrophil-lymphocyte ratio and severity of lower extremity peripheral artery disease. , 2017, International journal of cardiology.

[28]  Gongcheng Wang,et al.  High neutrophil‐to‐lymphocyte ratio is associated with increased carotid artery intima‐media thickness in type 2 diabetes , 2016, Journal of diabetes investigation.

[29]  T. Cha,et al.  The Combined Impact of Neutrophil-to-Lymphocyte Ratio and Type 2 Diabetic Mellitus on Significant Coronary Artery Disease and Carotid Artery Atherosclerosis , 2016, Journal of cardiovascular ultrasound.

[30]  W. Jung,et al.  Can the Neutrophil-to-Lymphocyte Ratio Appropriately Predict Carotid Artery Stenosis in Patients with Ischemic Stroke?-A Retrospective Study. , 2015, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[31]  C. Hedrick.  Lymphocytes in atherosclerosis. , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[32]  G. Limongelli,et al.  Inflammation and Cardiovascular Disease: From Pathogenesis to Therapeutic Target , 2014, Current Atherosclerosis Reports.

[33]  Guangyu Zhang,et al.  Neutrophil to lymphocyte ratio in relation to risk of all-cause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: a meta-analysis of observational studies. , 2014, Atherosclerosis.

[34]  A. Wang,et al.  Associations of high sensitivity C‐reactive protein levels with the prevalence of asymptomatic intracranial arterial stenosis , 2014, European journal of neurology.

[35]  Nileshkumar J Patel,et al.  Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality: insights from the National Health and Nutrition Examination Survey-III. , 2014, International journal of cardiology.

[36]  H. Kaya,et al.  Association Between Neutrophil to Lymphocyte Ratio and Severity of Coronary Artery Disease , 2014, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[37]  S. Humphries,et al.  Progression of Carotid Intima-Media Thickness as Predictor of Vascular Events: Results from the IMPROVE Study , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[38]  Enzo Grossi,et al.  Measurements of carotid intima-media thickness and of interadventitia common carotid diameter improve prediction of cardiovascular events: results of the IMPROVE (Carotid Intima Media Thickness [IMT] and IMT-Progression as Predictors of Vascular Events in a High Risk European Population) study. , 2012, Journal of the American College of Cardiology.

[39]  Oliver Soehnlein,et al.  Multiple roles for neutrophils in atherosclerosis. , 2012, Circulation research.

[40]  E. Falk,et al.  Risk factors for near-term myocardial infarction in apparently healthy men and women. , 2010, Clinical chemistry.

[41]  Christian Weber,et al.  Importance of CXC Chemokine Receptor 2 in the Homing of Human Peripheral Blood Endothelial Progenitor Cells to Sites of Arterial Injury , 2007, Circulation research.

[42]  S. Sheu,et al.  Association of peripheral total and differential leukocyte counts with metabolic syndrome and risk of ischemic cardiovascular diseases in patients with type 2 diabetes mellitus , 2007, Diabetes/metabolism research and reviews.

[43]  G. Moneta,et al.  Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease. , 2006, Journal of vascular surgery.

[44]  G. Dagenais,et al.  Inflammatory markers and long-term risk of ischemic heart disease in men A 13-year follow-up of the Quebec Cardiovascular Study. , 2005, Atherosclerosis.

[45]  C. Ballantyne,et al.  Markers of inflammation and their clinical significance. , 2005, Atherosclerosis. Supplements.

[46]  Shah Ebrahim,et al.  JOINT ESC GUIDELINES 2016 European Guidelines on cardiovascular disease prevention in clinical practice – Web Addenda , 2016 .

[47]  B. Horne,et al.  C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. , 2002, Journal of the American College of Cardiology.

[48]  G. Dagenais,et al.  Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men. , 2001, Archives of internal medicine.

[49]  M. Hori,et al.  C-Reactive Protein Is an Independent Predictor of the Rate of Increase in Early Carotid Atherosclerosis , 2001, Circulation.

[50]  J. Raffort,et al.  High Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are Associated with Symptomatic Internal Carotid Artery Stenosis. , 2019, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[51]  A. Pulvirenti,et al.  Neutrophil-to-Lymphocyte Ratio is a strong predictor of atherosclerotic carotid plaques in older adults. , 2018, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[52]  P. Akyol,et al.  Evaluation of white blood cell and neutrophil/lymphocyte ratio in acute coronary syndrome patients admitted to emergency department , 2018 .

[53]  E. Falk,et al.  Mechanisms of Plaque Formation and Rupture , 2014 .

[54]  A. Hoes,et al.  [Guidelines on cardiovascular disease prevention in clinical practice]. , 2005, Revue medicale de Liege.

[55]  A. Döring,et al.  C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men , 1998 .